×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕß £¬NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²âΪȫÇò¿Í»§Ìṩһվʽ¼ìÑé¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°¼¼Êõ·þÎñ¡£
·þÎñÄÜÁ¦ÒÑÈ«ÃæÁýÕÖµ½·ÄÖ¯·þ×°¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉú»î¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§½¡¿µ¡¢Ê³Æ·¼°Å©²úÎï……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£
È«Ãæ±£ÕÏÆ·ÖÊÓëÄþ¾² £¬Íƶ¯ºÏ¹æÓ봴Р£¬ÕÃÏÔÆ·ÅƾºÕùÁ¦ £¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü½¡¿µ¡¢¸üÄþ¾²¡¢¸üÂÌÉ«µÄ¿ÉÁ¬ÐøÉú³¤¡£
Ê×Ò³ > ÎÒÃǵķþÎñ > Ò½Ò©¼°Ò½Ñ§·þÎñ > Ò½ÁÆÆ÷е¼ì²â > ·þÎñÏêÇé
NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²âΪÄúÌṩҽÓÃÄÚ¿ú¾µÈ¡Ê¯Àº×¢²á¼ì²â £¬ÓµÓйú¼ÒCNAS/CMA×ÊÖÊ £¬¿ÉΪÄÚ¿ú¾µÈ¡Ê¯Àº²úÎïÉÏÊÐÌṩרҵµÄ²âÊÔ¡¢¼ìÑé¡¢ÉóºË¡¢×ÉѯµÈһվʽ¼¼Êõ·þÎñ¡£ÖúÁ¦ÄÚ¿ú¾µÈ¡Ê¯Àº²úÎïºÏ¹æ £¬¼øÖ¤ÖÊÁ¿Äþ¾² £¬¿ÉÁýÕֵļì²â·þÎñ·¶Î§ÓУºÉúÎïѧÆÀ¼Û¡¢Ãð¾úÑéÖ¤¡¢ÎÞ¾úÒ½ÁÆÆ÷е°ü×°ÑéÖ¤µÈ²âÊÔ·þÎñ¡£
ÔÚÎÒ¹úÒ½ÁÆÆ÷еע²á¹ÜÀíÖÐ £¬ÄÚ¿ú¾µÓÃȡʯÀºµÄ·çÏÕ¹ÜÀíÀà±ðÊÇIIÀࣻ
·ÖÀà±àÂëΪ£º02-15-18£¨02ÎÞÔ´ÊÖÊõÆ÷е-15ÊÖÊõÆ÷е-ÆäËûÆ÷е-18ÄÚ¿ú¾µÓÃȡʯÆ÷е£©£»
NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²â¿ÉÒÔΪÄúÌṩ¡¾ÄÚ¿ú¾µÈ¡Ê¯Àº¡¿×¢²á¼ì²â½â¾ö·½°¸ £¬¿ÉÁýÕֵļì²â·þÎñ·¶Î§ÓУºÉúÎïѧÆÀ¼Û¡¢Ãð¾úÑéÖ¤¡¢ÎÞ¾úÒ½ÁÆÆ÷е°ü×°ÑéÖ¤µÈ²âÊÔ·þÎñ¡£
²âÊÔÏîÄ¿ |
³ß¶È |
³ß¶ÈÃû³Æ |
| ÉúÎïѧÆÀ¼Û | GB/T 16886.1-2022 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ1²¿ÃÅ£º·çÏÕ¹ÜÀí¹ý³ÌÖеÄÆÀ¼ÛÓëÊÔÑé |
| GB/T 16886.5-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ5²¿ÃÅ£ºÌåÍâϸ°û¶¾ÐÔÊÔÑé | |
| GB/T 16886.10-2017 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ10²¿ÃÅ£º´Ì¼¤ÓëƤ·ôÖÂÃôÊÔÑé | |
| GB/T 16886.11:2021 | Ò½ÁÆÆ÷еÉúÎïѧÆÀ¼Û µÚ11²¿ÃÅ£ºÈ«Éí¶¾ÐÔÊÔÑé | |
| ISO 10993-1:2018 | Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process | |
| ISO 10993-5:2009 | Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity | |
| ISO 10993-10:2021 | Biological evaluation of medical devices Part 10: Tests for skin sensitization | |
| ISO 10993-11:2017 | Biological evaluation of medical devicesPart 11: Tests for systemic toxicity | |
| Ãð¾úÑéÖ¤ | GB 18280.2 / ISO11137-2 | ·øÉäÃð¾ú¼ÁÁ¿É趨 |
| GB/T 16886.7/ ISO 10993-7/GB/T 14233.1 | »·ÑõÒÒÍéÃð¾ú²ÐÁôÁ¿£¨EO/ECH£© | |
| WS 310.1/WS 310.2/WS 310.3/WS/T 367/GB 18278.1/AAMI TIR30:2011/(R)2016/ AAMI TIR 12-2020/ASTM F3208-20/ ISO 17664/ISO 20857/ISO 25424/ YY/T 0734/ YY/T 1495 | ÇåÏ´Ïû¶¾Ãð¾úÑéÖ¤ | |
| GB 18280.1:2015 | Ò½ÁƱ£½¡²úÎïÃð¾ú ·øÉä µÚ1²¿ÃÅ£ºÒ½ÁÆÆ÷еÃð¾ú¹ý³ÌµÄ¿ª·¢¡¢È·ÈϺÍͨÀý¿ØÖÆÒªÇó | |
| GB 18280.2:2015 | Ò½ÁƱ£½¡²úÎïÃð¾ú ·øÉä µÚ2²¿ÃÅ£º½¨Á¢Ãð¾ú¼ÁÁ¿ | |
| GB 18281.2:2015 | Ò½ÁƱ£½¡²úÎïÃð¾ú ÉúÎïָʾÎï µÚ2²¿ÃÅ£º»·ÑõÒÒÍéÃð¾úÓÃÉúÎïָʾÎï | |
| ÎÞ¾úÒ½ÁÆÆ÷е°ü×°ÑéÖ¤ | YY/T 0681ϵÁÐ | ÎÞ¾úÒ½ÁÆÆ÷е°ü×°ÑéÖ¤ |
| ÐÔÄÜ | GB/T 1962.1-2015 | ×¢ÉäÆ÷¡¢×¢ÉäÕë¼°ÆäËûÒ½ÁÆÆ÷е6%£¨Â³¶û£©Ô²×¶½ÓÍ· µÚ1²¿ÃÅ£ºÍ¨ÓÃÒªÇó |
| GB/T 1962.2:2001 | ×¢ÉäÆ÷¡¢×¢ÉäÕë¼°ÆäËûÒ½ÁÆÆ÷е6%(³¶û)Բ׶½ÓÍ· µÚ2²¿ÃÅ:Ëø¶¨½ÓÍ· | |
| GB/T 14233.1:2022 | Ò½ÓÃÊäÒº¡¢ÊäѪ¡¢×¢ÉäÆ÷¾ß¼ìÑéÒªÁì µÚ1²¿ÃÅ£º»¯Ñ§·ÖÎöÒªÁì | |
| GB/T 15812.1:2005 | ·ÇѪ¹ÜÄÚµ¼¹Ü µÚ1²¿ÃÅ:Ò»°ãÐÔÄÜÊÔÑéÒªÁì | |
| YY/T 0847-2011 | Ò½ÓÃÄÚ¿ú¾µ ÄÚ¿ú¾µÆ÷е ȡʯÍøÀº | |
| YY/T 0149:2006 | ²»Ðâ¸ÖÒ½ÓÃÆ÷еÄ͸¯Ê´ÐÔÄÜÊÔÑéÒªÁì |
±¸×¢£ºÈçÉϲâÊÔÏîÄ¿·ÇÈ«²¿£»½öÂÞÁг£¼ûµÄ³ß¶È¡£
ÍêÕûÄÜÕý³£ÊÂÇéµÄÑù»ú £¬ÆäËû¾ßÌåÏêÇéÇë×ÉѯNG28ÔÚÏß¿Í·þ¡£
1¡¢NG28¾ßÓÐרҵ×ÊÖÊ¡¢¾Ñ鸻ºñµÄ¼¼Êõר¼ÒÍÅ¶Ó £¬ÎªÄúÌṩרҵ×ÉѯºÍ·þÎñ¡£
2¡¢NG28ÓµÓÐÏȽøµÄʵÑéÊÒÉ豸 £¬È·±£²âÊÔÊý¾ÝµÄ׼ȷºÍ¿É¿¿¡£
3¡¢NG28×÷ΪȫÇò¿Í»§ÐÅÀµµÄµÚÈý·½²âÊÔÈÏÖ¤»ú¹¹ £¬ÎÒÃÇÊÇÄúÆ·Öʵı³Êé¡£
4¡¢ÎÒÃÇƾ½è±é²¼È«ÇòµÄʵÑéÊÒÍøÂç £¬ÎªÄúÌṩȫÃæÍêÉƵÄһվʽ²âÊÔÈÏÖ¤½â¾ö·½°¸¡£
NG28µÄÒ½ÁÆÆ÷е¼ì²âµÄ²âÊÔÖÜÆÚÊǶà¾Ã£¿
ʵ¼ÊÖÜÆÚƾ¾ÝίÍеIJúÎï³ß¶ÈÀ´È·¶¨ £¬ÇëÓëNG28¿Í·þÁªÏµÈ·ÈÏ¡£
NG28Ò½ÁÆÆ÷е¼ì²âµÄ²âÊÔÒªÁìÊÇʲô£¿
Õë¶Ô²úÎïµÄ³ö¿ÚÒªÒÔ¼°¿Í»§Î¯ÍеÄÒªÇó £¬½øÐг߶ȼì²â¡£
NG28¶ÔÓÚÑùÆ·µÄÁôÑùÖÜÆÚÊǶà¾Ã£¿
ÍËÑù¡£
Á®ÕþÉùÃ÷ | Òþ˽Õþ²ß | È«Çò·þÎñÍøÂç | ÍøÕ¾µØͼ | ͶËß¾Ù±¨ | ×ÔÎÒÉùÃ÷ | Ö´·¨ÉùÃ÷ | ¼ì²â·þÎñͨÓÃÌõ¿î Copyright Centre Testing International All rights reserved
ÔÁICP±¸10021358ºÅ 
ÔÁ¹«Íø°²±¸ 44030602000441ºÅ
Online Consultation
